%20(1).png?width=773&height=112&name=Generis%20Logo%20full%20Colour%20(Large)%20(1).png "Generis Logo full Colour (Large) (1)")
Introduction
The 12th Annual American Medical Device Summit made a powerful return this past October 2025, in Chicago, IL, once again serving as the leading platform where innovation meets opportunity in the MedTech industry. Over two dynamic days, more than 250 medical device executives and solution providers came together to exchange ideas, gain practical insights, and build lasting connections through engaging sessions, workshops, panels, lunch & learns, 1-2-1 meetings, and networking receptions.
Guiding the discussions throughout the summit were this year’s emcees — Jackie Kunzler, SVP & Global Head of R&D at Terumo Blood and Cell Technologies; Elena Mack, Chief Quality Officer at SaniSure; John Peyton, VP of Customer Success at Clarivate Analytics; and Dane Popovski, Senior Director of Regulatory Affairs at BD.
Across four key content streams — Design, Product Development, Quality & Regulatory, and Innovation — attendees explored the latest advancements shaping the future of medical devices, from wearable health tech and AI-driven engineering to evolving regulatory frameworks and next-generation design excellence. The result was two days filled with knowledge sharing, collaboration, and inspiration—cementing the summit’s role as a cornerstone event for leaders driving progress across the global MedTech landscape.
Table of Contents
Day 1 Recap - Momentum, Insight, and Connection
Day 2 Recap - Leadership, Collaboration & The Future of MedTech
Day 1 Recap - Momentum, Insight, and Connection
Day 1 of the American Medical Device Summit opened with an unmistakable sense of anticipation. As attendees filled the ballroom, conversations buzzed with curiosity about the technologies, regulatory shifts, and innovations poised to define the next era of MedTech. The energy set the stage perfectly for the day’s first voice: a warm and forward-looking Welcome Address from Tom Dailly, Mayor of the Village of Schaumburg, who highlighted the region’s thriving footprint in medical technology and its commitment to fostering industry growth.
From there, the program launched into its first keynote. Ganesh Mayya, SVP, Software Engineering, GE HealthCare Imaging, of GE HealthCare, took the stage for the first keynote of the summit, guiding the audience through the importance of cross-functional collaboration in modern imaging innovation. His keynote set a collaborative tone that echoed throughout the rest of the day.
The momentum continued into the morning plenaries. First, Shital Patel of ECI, Michelle Wu of Nyquist AI, and Adam Foresman of Ryden Solutions explored how AI is reshaping quality and regulatory compliance.
The next plenary featured Kim Kaplan of The Voluntary Improvement Program, who shared the transformational impact of quality maturity models—providing a clear reminder that quality, when embraced cross-functionally, can be a strategic engine that drives growth, collaboration, and regulatory confidence.
A mid-morning break offered attendees time to recharge, meet new peers, and join pre-scheduled 1-2-1 meetings—a highlight for many who arrived with specific challenges, partnership goals, or product development questions in mind.
Breakout Sessions and Workshops: Unfolding Day 1
The agenda then unfolded into a series of concurrent sessions, each touching on the diverse and evolving challenges facing the industry.
Alind Sahay from Pentax Medical (HOYA Corporation) shared perspectives on AI-enabled, patient-centric innovation and how engineers can thoughtfully integrate artificial intelligence into development workflows. Kamaal Anas of B. Braun Medical offered strategies for turning global regulatory insights into actionable product development advantages across cross-functional teams.
Simultaneously, Mizanu Kebede of Smith & Nephew discussed the evolving demands of EU MDR, while Cynthia Hougum, Ph.D., from Getinge explored the future of cardiovascular surgery, emphasizing digital transformation, global expansion, and innovation-driven patient outcomes.
Alongside these sessions, the morning workshops provided deeper, hands-on learning. MethodSense walked attendees through the realities of regulating AI in MedTech, comparing U.S. FDA history to Europe’s developing AI Act. Infineon Technologies broke down supply chain threats and the role of security ICs in protecting patient safety. IZiel Healthcare examined how to strategically identify AI efficiency opportunities, while Ansys demonstrated how digital engineering and in silico trials are accelerating innovation and reducing reliance on physical prototypes.
When lunchtime arrived, attendees dispersed across a series of Lunch & Learn Roundtable Discussions hosted by ECI, Providence Enterprise, Agiliad, Mission Plastics Inc., BSI Compliance Navigator, HID, CriTech, Keysight Technologies, Ascential, Qualitest, Clarivate Analytics, Veeva MedTech, Ascend Performance Materials, The Voluntary Improvement Program, QNX, SQA Services, and PTC Inc. Conversations ranged from compliance best practices to sustainable materials to next-gen digital tools—and it was clear that every table offered shared problem-solving, not just presentations.
Afternoon Conversations
The afternoon sessions resumed with renewed energy. Madhu Ayyagari, PH.D., of HOYA Surgical Optics shared strategies for enhancing medical device lifecycle management using real-world data and post-market analytics, while Vish Charan from Abbott highlighted pathways to accelerate product development through user-centered design and cross-functional collaboration. Just down the hall, Vishvas Garg, PH.D., from AbbVie offered practical guidance on leveraging FDA CFL guidance to communicate device value through outcomes, economics, and real-world evidence.
Afternoon workshops then brought another wave of practical learning. Nefab led conversations on sustainable packaging innovation and life cycle assessment. Agiliad demonstrated advanced medical imaging and AI platforms designed for modern clinical environments. RegDesk explored how technology and automation are reshaping regulatory affairs, while Battelle showcased material science and engineering breakthroughs enabling safer, more sustainable medical devices.
As the day progressed into its final plenary discussions, the room reconvened for two powerful, forward-looking conversations. Kamaal Anas, CVP, Regulatory Affairs, B. Braun Medical from B. Braun Group, and Amra Racic, VP Government Strategy from Veeva MedTech explored how AI, quality culture, and regulatory leadership are reshaping how companies navigate global regulatory demands. This was followed by insights from Youzhi Li, Ph.D., Director, MedTech Instrumentations, from Keysight Technologies, who delved into compliance, simulation, wireless coexistence, and cybersecurity readiness—an increasingly critical area for innovators across the device spectrum.
The final mainstage session of the day—a panel featuring leaders from Abbott, BD, Merz Aesthetics, Medical Device Innovation Consortium, and L&T Technology Services—brought everything together. In a dynamic conversation, they discussed how to structure product development for innovation, quality, regulatory alignment, and patient-centricity. Their dialogue spotlighted everything from MDR/IVDR impacts to agile design processes and emerging technologies—closing the day with inspiration and tangible takeaways.
The day ended with a lively Networking Drinks Reception, sponsored by L&L Technology Services, complete with signature cocktails and continued conversation.
Day 2 Recap - Leadership, Collaboration & The Future of MedTech
Day 2 of the American Medical Device Summit began with the soft hum of conversation drifting through the networking breakfast—coffee in hand, attendees reconnecting with familiar faces and meeting new ones before another full day of insight unfolded. The room quickly filled as guests took their seats for the morning’s opening conversation: a powerful Women in Leadership Panel that set an inspiring tone for the day.
Moderated by Jacqueline Huber of Medacta USA, the panel featured five remarkable leaders—Emily Gallo of Cardinal Health, Brigitte Schiller of Fresenius Medical Care, Medha Trivedi of BD, Tracey Fox of Olympus Corporation of the Americas, and Melissa Kann of Stryker. Through deeply personal reflections and candid conversations, they explored leadership lessons learned over decades, the barriers they navigated, and how they each work to cultivate the next generation of women leaders across MedTech.
Next came a keynote that continued the theme of collaboration and progress. Robert Kossmann, EVP and Chief Medical Officer at Fresenius Medical Care, walked attendees through the critical role of cross-functional alignment in driving advances in renal care. He spotlighted the power of intertwining R&D, product design, and clinical insight—showing through case studies how multidisciplinary teams accelerate innovation and directly improve patient outcomes.
The morning then transitioned into a thoughtful plenary delivered by Chetan Makam of Terumo Blood and Cell Technologies, who explored the full lifecycle of bringing advanced blood and cell therapy solutions to the market.
The Learning Continues with Workshops, Sessions, and Roundtable Discussions
With ideas flowing, attendees moved into two rounds of hands-on workshops, each room offering a different lens into the capabilities shaping the future of medical technology. Companies such as Ascential Medical & Life Science, QNX, Porex Filtration Group, TEAM Technologies, L&T Technology Services, BD and Sigmoid, Ketryx, and Infosys Limited led explorations into AI frameworks, machine vision in manufacturing, automation in the AI era, advancements in blood separation membranes, and agentic AI applications across development and engineering. Each workshop offered a practical, real-world look at how emerging technologies are being operationalized across the MedTech lifecycle.
Late morning sessions then opened across four rooms, tackling some of the industry’s most pressing challenges, where Merz Aesthetics presented strategies for mastering risk management in device safety. Butterfly Network explored regulatory strategies designed to support sustainable, long-term growth. Johnson & Johnson shared how generative AI can digitize and elevate quality systems. Finally, in Room 4, Baxter, joined by Terumo Blood and Cell Technologies, led a fireside chat on how connected care ecosystems drive meaningful clinical and operational outcomes.
As lunchtime approached, attendees dispersed into a diverse collection of Lunch & Learn Roundtables, hosted by organizations including Gentell, XVIVO, Siemens Healthineers, BD, Pfizer, FlexDex Surgical, Medacta USA, Alcon Research, SaniSure, Baxter, and Medtronic. Conversations ranged from AI in SaMD, to wound-care supply chain innovation, to talent strategy to regulatory agility, to R&D collaboration. Each table became a space for candid discussion, technical exchange, and shared problem-solving—the kind of insight only possible when peers come together with aligned challenges.
Final Takeaways
After lunch, the room reconvened for a plenary that blended perspectives across major segments of the MedTech ecosystem. John Leamy of Johnson & Johnson, John Peyton of Clarivate Analytics, and Mitch Hayes of Clarivate Analytics offered a cross-segment view of what AI-driven productivity looks like within quality systems. Their conversation spanned the operational steps needed to deploy agentic and generative AI, regulatory challenges, and the growing need for standardization.
The final mainstage session of the summit, a dynamic Panel Discussion on MedTech Talent, brought together leaders from across the industry: Chetan Makam of Terumo Blood and Cell Technologies, Chad Malone of Philips, Cynthia Hougum of Getinge, and David Navazio of Gentell. Together, they addressed one of the most urgent challenges facing MedTech organizations today: attracting, retaining, and nurturing the next generation of engineering, regulatory, and technical talent.
As Day 2 wound down and attendees shared final conversations before heading home. Across two days, the community absorbed knowledge, exchanged ideas, and forged relationships that will push MedTech forward long after the summit’s close.
Conclusion
The American Medical Device Summit closed with a clear sense of momentum—an industry stepping confidently into its next era. Over two days, leaders, innovators, and technical experts came together to exchange ideas, challenge assumptions, and outline the strategies that will define the future of MedTech. Across every keynote, panel, workshop, and roundtable, one message consistently emerged: progress in this industry is not driven by individual breakthroughs, but by the collective strength of a community committed to advancing patient care.
As attendees return to their organizations, they carry with them new connections, actionable insights, and a renewed commitment to shaping safer, smarter, more connected medical technologies. The conversations sparked here will continue to influence decisions, inspire innovation, and strengthen operational excellence long after the summit’s close.
Thank you to all who joined us. Together, we are pushing the boundaries of what’s possible—and laying the groundwork for a future where technology and collaboration transform healthcare for the better.
Visit amdsummit.com to learn more and secure your spot at our 13th annual event, on October 26-27, 2026 returning to the Renaissance Schaumburg Convention Center Hotel in Chicago, IL!
Testimonials
“As a first-time attendee from a start-up, the conference was an excellent introduction to the many facets surrounding medical device design, launch, safety, and compliance.”
Craig Glaiberman, Chief Medical Officer @ Epica International
"The proactive approach to drive networking is really helping to facilitate connections within the limited time of the summit. Namely the round table pre-registration and the Generis staff walking around and grabbing people into meetups, making sure they happen on time."
Alon Hazan, CTO @ RetiSpec
“The American Medical Device Summit provides a unique opportunity to connect with both attendees and sponsors through learning, focused discussion, defined meetings and freeform networking.”
Emily Skanron, Director of Quality and Regulatory @ FlexDex Surgical
"This was an extraordinary summit for networking with fellow medical device peers in one place. The most productive discussions were the many workshops, networking opportunities, 1-2-1 meetings, and lunch collaboration events, and I loved participating in them to expand my network."
Hari Krishna Kapparapu, Associate Director @ Alcon
“The summit has been a great experience allowing us to engage and connect, both with peers in the industry and with vendor partners to learn of emerging trends and technologies. The speaker series were insightful and prompted thoughts and provided perspectives to our own challenges being faced.”
Dhruv Bhojwani, Director, Business Solutions and Digital Transformation, Global Supply Chain @ Edwards Lifesciences
“Well-organized and content-rich, the Generis American Medical Device Summit delivered strong discussions and connections within the medical device community.”
Iman Benchehida, Senior Customer Quality Engineer @ Stryker
“Such a unique experience discussing product development and quality. Many interesting topics were covered, I was spoiled with choices and variety. Learned so much about AI and culture of quality.”
Niketha Kailash, Senior Quality Engineer Design Assurance @ Mammotome
“The American Medical Device Summit 2025 was an excellent platform for knowledge exchange and networking. The sessions were thoughtfully curated, covering key trends in digital transformation, regulatory compliance, and quality innovation. I particularly appreciated the mix of strategic discussions and practical case studies. The event provided valuable insights and meaningful connections that will directly influence upcoming initiatives in our organization.”
Vamsi Kothapalli, Business Analyst Leads @ Arthrex
Learn more about our upcoming 2026 North American events, and secure your spot today:
- American Manufacturing Summit | March 17-18, 2026
- American Biomanufacturing Summit | April 14-15, 2026
- American Supply Chain Summit | April 27-28, 2026
- American Packaging Summit | May 14-15, 2026
- American CIO & Cybersecurity Summit | June 9-10, 2026
- American Electronics & High-Tech Manufacturing Summit | June 16-17, 2026
- ...and more 2027 events!
Subscribe so you never miss another blog!
.png)
.jpg)